Author(s) Details:
Abdullah M. Nasrat
Zaitona Medical Center, Medina, Saudi Arabia.
Rania Ashour
Al Hayat National Hospital, Medina, Saudi Arabia.
This section is a part of the chapter: An Approach for the Hematologic Challenges of Helicobacter pylori in Children: An Expensive Cost of Parents’ Misbehavior towards their Kids
Although the eradication regimens efficiently eradicate H. pylori; the emergence of antibiotic-resistant H. pylori strains, the severe side effects, the high costs, treatment failure and high chances of recurrence are major drawbacks of these treatments (Ge, 2002; Nasrat & Nasrat 2015). More efficient, economical and friendly drugs need to be developed, especially for children and in particular those with hematologic challenges. Amazingly; H. pylori may not be just a bad bug in all instances, as complete eradication of the organism might introduce new problems due to the low gastric acidity. H. pylori has been shown to be a protective agent against low pH level-related carcinomas involving the cardia of the stomach (Farinha & Gascoyne 2005); that is a greatly confusing challenge.
How to Cite
Nasrat, A. M., & Ashour, R. (2025). An Approach for the Hematologic Challenges of Helicobacter pylori in Children: An Expensive Cost of Parents’ Misbehavior towards their Kids. Medical Science: Trends and Innovations Vol. 4, 20–26. https://doi.org/10.9734/bpi/msti/v4/4043